OCRA Team
Meet Our Team
OCRA is fortunate to have a Board composed of distinguished leaders, a team of talented, caring Staff members, and a renowned Scientific Advisory Committee, who between them have decades of experience fighting ovarian and related gynecologic cancers. Passionate, knowledgeable, and innovative, they are dedicated to improving the lives of those touched by the disease through advancing research, creating imaginative, empathic support programs, encouraging industry collaboration, and fighting legislative battles on Capitol Hill.
Learn About Our Team Members
Never doubt that a small group of thoughtful committed citizens can change the world: indeed, it’s the only thing that ever has.
– Margaret Mead
Related Topics
Mission & Impact
OCRA is dedicated to improving treatments by advancing innovative research, supporting with expertise and empathy those affected by gynecologic cancers to ensure the best possible care and outcomes, raising awareness, and advocating for legislation that tangibly improves patients’ lives.
OCRA Invests More than $10.8 Million Toward Research, Part of $14.5 Million Commitment in 2025
In 2025, Ovarian Cancer Research Alliance (OCRA) invested more than $10.8 million toward scientific research—part of our $14.5 million commitment to strengthen the community through research, patient support, education and advocacy. This year’s investment represents OCRA’s broadest scope to date, encompassing not only our renowned grant programs but also global collaborations leveraging artificial intelligence (AI) … Continued
The Overview: October 2025
KVIA-TV ABC-7 News El Paso recently featured OCRA-funded researcher Daniel Heller, PhD, and his team at Memorial Sloan Kettering Cancer Center, whose innovative work is bringing new hope for detecting ovarian cancer at its earliest stages through a simple blood test. Dr. Heller’s research lab is developing a liquid biopsy that uses nanosensors and artificial intelligence (AI) to measure multiple proteins … Continued